Found 0 matching trials
The 1st Tumor CytokinoTherapy Database (TCTD-1)
N/APredicting the response of patients diagnosed with cancer to cytokinotherap...
Location
OncocareClinic 308
Study of IFN-α Combined With CAR-T Cell Therapy in Relapsed and Refractory Acute Lymphoblastic Leukemia(R/R-ALL)
PHASE2The purpose of this study is to evaluate the safety and efficacy of IFN-α c...
Location
The First Affiliated Hospital of Soochow University
PEG-Interferon Alfa-2b in Treating Patients With Platinum-Resistant Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer
PHASE1RATIONALE: PEG-interferon alfa-2b may interfere with the growth of cancer c...
Location
M D Anderson Cancer Center
Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis
PHASE3We conducted a randomized controlled trial of adjuvant interferon (IFN) the...
Location
National Cancer Institute
The Treatment of PD-1 Antibody Combined With Peg-IFNα in NAs-suppressed CHB Patients
NAThis is a prospective, open-labled, randomized controlled study to assess e...
Status
Active Not Recruiting
Location
the Fifth Medical Center, Chinese PLA General Hospital
Hansenula-derived Pegylated Interferon in Treatment of Patients With Chronic Hepatitis C
PHASE4It is a multi-center study of the efficacy of a new Pegylated Hansenula-der...
Location
National Liver Institute
Interleukin-2 and Interferon in Treating Patients With Metastatic Kidney Cancer
PHASE3RATIONALE: Biological therapies, such as interleukin-2 and interferon, may ...
Location
Multiple Locations
Sequential Combination Therapy With PD-1 Antibody and Peg-IFNα in CHB Patients
NAThis is a prospective study to evaluate the safety and efficacy of Sintilim...
Location
the Fifth Medical Center, Chinese PLA General Hospital
Early Response to Interferon Combined Short-Term Nucleoside Analogue Therapy in HBeAg(+) Chronic Hepatitis B
NAFor HBeAg(+) patients, interferon is used for 12 weeks. On 12th week of tre...
Location
The Third Affliated Hospital of Sun Yat-sen University
HBsAg Decline After Pegylated-interferon-α in e Antigen Positive Chronic Hepatitis B With Nucleoside Maintenance
PHASE3This study proposes to compare the effect of 48 weeks exposure to pegylated...
Location
Pusan National University Hospital